Rosetta Genomics' Q4 Spending Swells in Preparation for 2008 Dx Launches | GenomeWeb
NEW YORK (GenomeWeb News) – Rosetta Genomics today said in its earnings report for the fourth quarter of 2007 that it is “solidly on target” to launch three diagnostic microRNA tests in the coming year, but as it currently has no products on the market it posted no revenues for 2007.
 
In addition, the company’s net loss nearly tripled as it spent more on increased R&D and selling and general expenses rose.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.